Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

PADI4 enzyme slows down cell growth in developing hair follicles.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Silencing SFRP1 alone promotes hair growth, but adding DKK1 does not help.

AMPK activation may reduce melanoma risk in red-haired individuals.

Gefitinib can cause hair loss without scarring.

L-threonate may help prevent balding by blocking a key hair loss factor.

A new compound, HTPI, promotes hair growth by protecting cells from damage and regulating energy use.

Baricitinib effectively promotes beard regrowth in most men with alopecia areata universalis.

Follistatin is important for hair growth and could help treat hair loss.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Finasteride increases CD8+ T cells in BPH tissues.

Terminalia bellirica extracts effectively promote hair regrowth and treat androgenetic alopecia.

A protein complex called mTORC1 likely affects when hair growth starts in mice.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

JW0061 may be a new treatment for hair loss by promoting hair growth through WNT signaling.

Nfib in hair follicle stem cells boosts melanocyte stem cell growth and differentiation.

EGFR inhibitors can cause unusual localized hair growth.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Progerin affects cell shape but not hair or skin in mice.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

High androgen levels and genetic factors likely cause Becker's nevus and related symptoms.

Blocking certain proteins in mouse skin can reduce and shrink skin tumors.

P-cadherin is crucial for hair follicle pigmentation but not skin pigmentation.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

Baricitinib works better than methotrexate for severe alopecia areata.

Fibrosis in the bulge area of hair follicles can cause hair thinning in male pattern baldness, and drugs that inhibit fibrosis might help reverse this.